19.84
price down icon2.07%   -0.42
after-market Handel nachbörslich: 19.83 -0.01 -0.05%
loading
Schlusskurs vom Vortag:
$20.26
Offen:
$19.77
24-Stunden-Volumen:
4.19M
Relative Volume:
1.68
Marktkapitalisierung:
$4.73B
Einnahmen:
$426.45M
Nettoeinkommen (Verlust:
$197.67M
KGV:
24.20
EPS:
0.82
Netto-Cashflow:
$110.10M
1W Leistung:
-2.36%
1M Leistung:
+21.05%
6M Leistung:
-0.75%
1J Leistung:
+200.61%
1-Tages-Spanne:
Value
$17.87
$19.91
1-Wochen-Bereich:
Value
$17.87
$20.70
52-Wochen-Spanne:
Value
$5.895
$23.64

Adma Biologics Inc Stock (ADMA) Company Profile

Name
Firmenname
Adma Biologics Inc
Name
Telefon
(201) 478-5552
Name
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Name
Mitarbeiter
685
Name
Twitter
@AdmaBiologics
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
ADMA's Discussions on Twitter

Vergleichen Sie ADMA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ADMA
Adma Biologics Inc
19.84 4.73B 426.45M 197.67M 110.10M 0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-07-19 Fortgesetzt Raymond James Strong Buy
2022-10-13 Eingeleitet Mizuho Buy
2021-11-11 Hochstufung Raymond James Outperform → Strong Buy
2021-11-09 Eingeleitet Cantor Fitzgerald Overweight
2019-06-04 Eingeleitet Jefferies Buy
2019-04-15 Bestätigt H.C. Wainwright Buy
2019-02-07 Fortgesetzt H.C. Wainwright Buy
2017-12-11 Bestätigt Maxim Group Buy
2017-11-14 Hochstufung Raymond James Mkt Perform → Outperform
2017-01-23 Hochstufung Maxim Group Hold → Buy
2016-08-01 Herabstufung Maxim Group Buy → Hold
2016-07-25 Bestätigt Maxim Group Buy
2015-05-13 Bestätigt Maxim Group Buy
2014-12-08 Eingeleitet Oppenheimer Outperform
2014-12-01 Bestätigt Maxim Group Buy
Alle ansehen

Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten

pulisher
09:30 AM

Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest? - Yahoo Finance

09:30 AM
pulisher
Mar 28, 2025

Adma Biologics (ADMA) Stock Moves -0.15%: What You Should Know - Yahoo Finance

Mar 28, 2025
pulisher
Mar 27, 2025

How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback - MSN

Mar 27, 2025
pulisher
Mar 26, 2025

Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

Mar 26, 2025
pulisher
Mar 23, 2025

Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains? - MSN

Mar 23, 2025
pulisher
Mar 21, 2025

Adma Biologics CEO Adam Grossman sells $397,320 in stock By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

Adma Biologics CEO Adam Grossman sells $397,320 in stock - Investing.com

Mar 21, 2025
pulisher
Mar 21, 2025

Here is What to Know Beyond Why ADMA Biologics Inc (ADMA) is a Trending Stock - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential - Seeking Alpha

Mar 21, 2025
pulisher
Mar 21, 2025

Wall Street Analysts Predict a 39.08% Upside in Adma Biologics (ADMA): Here's What You Should Know - Yahoo Finance

Mar 21, 2025
pulisher
Mar 20, 2025

ADMA Stock Builds A Base As Profits Continue To Soar - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Pulse of the Market: Wednesday’s 10 Top Performers - Insider Monkey

Mar 20, 2025
pulisher
Mar 20, 2025

Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus

Mar 20, 2025
pulisher
Mar 19, 2025

Why ADMA Biologics Inc. (ADMA) Went Up On Wednesday? - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Why Adma Biologics (ADMA) Outpaced the Stock Market Today - MSN

Mar 19, 2025
pulisher
Mar 14, 2025

Will ADMA Biologics Stock Continue Its Momentum in 2025? - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

Should You Invest in Adma Biologics (ADMA) Based on Bullish Wall Street Views? - Yahoo Finance

Mar 13, 2025
pulisher
Mar 12, 2025

Adma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance

Mar 12, 2025
pulisher
Mar 11, 2025

What's Driving the Market Sentiment Around ADMA Biologics? - Benzinga

Mar 11, 2025
pulisher
Mar 10, 2025

Commit To Buy ADMA Biologics At $10, Earn 14% Using Options - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Bank of New York Mellon Corp Has $26.09 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

Mar 10, 2025
pulisher
Mar 10, 2025

Mutual of America Capital Management LLC Has $614,000 Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Adma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year Outlook - MSN

Mar 09, 2025
pulisher
Mar 09, 2025

Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 08, 2025

Lisanti Capital Growth LLC Sells 59,565 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Mar 08, 2025
pulisher
Mar 06, 2025

Mizuho lifts ADMA Biologics price target to $32, maintains Outperform - Investing.com

Mar 06, 2025
pulisher
Mar 05, 2025

How Much Upside is Left in Adma Biologics (ADMA)? Wall Street Analysts Think 52.85% - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

ADMA Biologics Stock Climbs Amid Strong Earnings - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

ADMA Biologics (NASDAQ:ADMA) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Buy Rating Affirmed for ADMA Biologics Amid Transition to New Auditor and Growth Prospects - TipRanks

Mar 05, 2025
pulisher
Mar 04, 2025

ADMA Biologics Earnings Call Highlights Strong Growth - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics Inc earnings beat by $0.31, revenue topped estimates - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

BREAKING: Block & Leviton Investigating ADMA Biologics, - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed - EIN News

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics slips as 10-K delay overshadows earnings beat - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics stock slips on 10-K delay (ADMA:NASDAQ) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics Reports Strong 2024 Financial Performance - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics Inc (ADMA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics Inc (ADMA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Mar 04, 2025

Finanzdaten der Adma Biologics Inc-Aktie (ADMA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Kapitalisierung:     |  Volumen (24h):